BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  BioCapital

  Researchers Suggest Genetics Might Be Behind Patient Response to COVID-19

  As the pandemic progresses, researchers are attacking the virus from every angle, and also learning more and more about how and why the virus affects who it does.

  April 8, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Insulin Makers Eli Lilly, Novo Nordisk and Sanofi Provide Low-Cost Options for Patients During COVID-19 Outbreak

  Many people have lost their jobs and, as a result, their insurance. That can be daunting enough, but for those who need life-saving drugs such as insulin, the situation is magnified.

  April 8, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Career Advice

  3 Tips for Growing Your Professional Network While Working from Home

  Many people are wondering how they can make meaningful connections and grow their professional network in a time when large group meetings are discouraged.

  April 8, 2020

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Business

  Arrakis Enters Multi-Billion Dollar Deal with Roche to Develop RNA-based Therapies

  “We are excited to partner with Roche’s strong research and development team,” said Michael Gilman, Arrakis’ chief executive officer.

  April 8, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  BioSpace Global Roundup, April 9

  Biopharma companies from across the globe provide updates to their business operations and pipelines.

  April 8, 2020

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  Sage Therapeutics Slashes 53% of Workforce to Focus Resources on Pipeline

  Following a setback with its experimental major depressive disorder drug in December, Sage Therapeutics will initiate a corporate restructuring that includes halving its employee headcount in order to focus its resources on the development of its pipeline.

  April 8, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Revolutionizing the Manufacturing Process for Faster Vaccine and Therapeutic Production

  The fastest way to get a safe, effective vaccine for COVID-19 to physicians and patients is to build upon an existing vaccine with an already-established manufacturing and supply chain…or to revolutionize the manufacturing process.

  April 8, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Biopharma Update on the Novel Coronavirus: April 8

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.

  April 8, 2020

   · 

  7 min read

   · 

  BioSpace Editorial Staff
• 

  Business

  venBio Closes $394 Million Life Sciences VC Fund

  The capital was raised from existing and new investors, including a broad range of institutional investors comprised of pharmaceutical companies, corporate pensions, financial institutions, endowments and foundations, family offices and funds-of-funds.

  April 8, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Acceleron’s Clinical PAH Drug Wins Breakthrough Therapy Designation

  The designation will allow the company to expedite the development and potential regulatory review of sotatercept.

  April 8, 2020

   · 

  2 min read

   · 

  Alex Keown